Novavax
NVAX
#5428
Rank
S$1.83 B
Marketcap
S$11.19
Share price
-2.18%
Change (1 day)
11.62%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): S$0.62 Billion

According to Novavax's latest financial reports the company's current earnings are S$1.08 Billion. , an increase over its 2024 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 S$0.59 B-396.87%
2024 -S$0.21 Billion-70.39%
2023 -S$0.68 Billion-16.59%
2022 -S$0.82 Billion-62.58%
2021 -S$2.17 Billion320.54%
2020 -S$0.52 Billion234.22%
2019 -S$0.16 Billion-30.17%
2018 -S$0.23 Billion1.69%
2017 -S$0.22 Billion-36.44%
2016 -S$0.35 Billion70.4%
2015 -S$0.21 Billion89.27%
2014 -S$0.11 Billion59.83%
2013 -S$66.36 Million81.9%
2012 -S$36.48 Million50.33%
2011 -S$24.27 Million
2009 -S$47.89 Million8.8%
2008 -S$44.02 Million18.01%
2007 -S$37.3 Million18.33%
2006 -S$31.52 Million168.31%
2005 -S$11.75 Million-62.51%
2004 -S$31.34 Million52.4%
2003 -S$20.57 Million-28.21%
2002 -S$28.65 Million
2000 -S$16.33 Million177%
1999 -S$5.9 Million-11.54%
1998 -S$6.67 Million10.64%
1997 -S$6.03 Million-9.62%
1996 -S$6.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.21 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.56 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.78 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.82 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.9 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.46 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.41 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.34 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA